Condition
Acute Lung Injury clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Acute Lung Injury clinical trials that are recruiting, at sites in 3 countries (most in Germany (2), United States (2), China (1)). By phase: Phase 2 (2), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 3Countries
Newest Acute Lung Injury clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| See if 18F-FAPI-74 PET/CT can better detect fibrosis in heart and lung disease | Phase 3 | Bethesda, Maryland | Recruiting | May 29, 2026 |
| Safety and performance of the Novalung kit and Xenios 2.0 during stationary use for patients on ECMO | — | Erfurt, Bavaria and 2 other locations | Recruiting | Sep 5, 2025 |
| MiniLung petite kit for neonates and infants with severe respiratory or cardiac failure | — | Bonn, North Rhine-Westphalia and 1 other locations | Recruiting | Dec 27, 2024 |
| IC14 (anti-CD14) treatment for hospitalized patients with ARDS | Phase 2 | Seattle, Washington and 1 other locations | Recruiting | Jul 22, 2024 |
| Using Pirfenidone to Prevent Lung Injury After Breast Cancer Radiation | Phase 2 | Fuzhou, Fujian | Recruiting | Jan 30, 2023 |
All recruiting trials (5)
-
See if 18F-FAPI-74 PET/CT can better detect fibrosis in heart and lung disease
Researchers are testing a new PET/CT tracer, 18F-FAPI-74, to see if it can reveal early fibrotic changes in people with heart and lung diseases who are at risk for tissue scarring.
-
Safety and performance of the Novalung kit and Xenios 2.0 during stationary use for patients on ECMO
This observational study tests whether using the Novalung ultimate kit with Xenios 2.0 (and MultiSupport Ground) helps maintain blood oxygenation in adults on ECMO during hospital stay and ground transport.
-
MiniLung petite kit for neonates and infants with severe respiratory or cardiac failure
We will test whether the MiniLung petite kit with the Xenios console safely improves oxygenation, removes CO2, and stabilizes circulation in newborns and young infants (2–8 kg) with severe respiratory or cardiopulmonary failure.
-
IC14 (anti-CD14) treatment for hospitalized patients with ARDS
This will test whether IC14, an antibody that blocks CD14, can improve oxygenation in adults hospitalized with ARDS who are on mechanical ventilation.
-
Using Pirfenidone to Prevent Lung Injury After Breast Cancer Radiation
This study is testing if the drug pirfenidone can help prevent lung damage in breast cancer patients receiving high-dose radiation treatment.
Related topics
Quick answers
How many Acute Lung Injury clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in Germany (2 trials), United States (2 trials), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.